Abstract
Background: Among the various phenolics metabolites, ferulic acid is considered as the promising mitigating, restorative and antioxidant agent. Ferulic acid is one of the most commonly found natural products in vegetables, for example, tomatoes, sweet corn, and in rice grain. Phytochemicals are utilized in the treatment of human ailments and these are derived from the dietary compounds.
Objective: The present review widely argued the calming restorative capability of ferulic acid alongside the scientific evidences and its proposed mechanism for activity. Furthermore, we provided the main practical points for the use of ferulic acid in oxidative damages during various diseases. Additionally, the relevant patents on ferulic acid with various therapeutic potential has been discussed.
Methods: The approach consisted of searching several resources, including theses, technical reports, web-based scientific databases such as publications on PubMed, ScienceDirect, Springer, PROTA, Google Scholar, and other allied databases. Thus, recent patent regarding the role of ferulic acid therapeutic potenitial has been discussed.
Results: One hundred and twenty references have been cited in the present review article. The cited references were found to be suitable and described the therapeutic application of ferulic acid thoroughly.
Conclusion: Ferulic acids are known to contrarily down-manage an assortment of extracellular and intrcelullular molecular targets related to infection movement. Various patents on ferulic acid based moieties have been accounted for from 2018. The ferulic acids have a wide scope of impacts against different infections like malignant growth, diabetes, cardiovascular and neurodegenerative diseases. The current review deals with the antioxidant property of ferulic acid and the recent patent describes the role of ferulic acid against human diseases.
Keywords: Antidiabetic effect, anti-inflammatory, antioxidants, ferulic acid, lipid peroxidation, neurodegeneration, phytochemicals.
[1]
Mahima VA, Tiwari R, Karthik K, Chakraborty S, Deb R, Dhama K. Nutraceuticals from fruits and vegetables at a glance: A review. J Biol Sci 2013; 13(2): 38-47.
[2]
Soobrattee MA, Neergheen VS, Luximon-Ramma A, Aruoma OI, Bahorun T. Phenolics as potential antioxidant therapeutic agents: Mechanism and action. Mutat Res 2005; 579: 200-13.
[3]
Chaudhary A, Choudhary S, Sharma U, Vig AP, Arora S. In vitro evaluation of Brassica sprouts for its antioxidant and antiproliferative potential. Indian J Pharm Sci 2016; 78(5): 615-23.
[4]
Chaudhary A, Choudhary S, Sharma U, Vig AP, Singh B, Arora S. Purple head broccoli (Brassica oleracea L. var. italica Plenck), a functional food crop for antioxidant and anticancer potential. J Food Sci Technol 2018; 55(5): 1806-15.
[5]
Chaudhary A, Rampal G, Sharma U, et al. Anticancer, antioxidant activities and GC-MS analysis of glucosinolates in two cultivars of broccoli. Med Chem Drug Disc 2012; 2: 30-7.
[6]
Chaudhary A, Sharma U, Vig AP, Singh B, Arora S. Free radical scavenging, antiproliferative activities and profiling of variations in the level of phytochemicals in different parts of broccoli (Brassica oleracea italica). Food Chem 2014; 148: 373-80.
[7]
Silva EO, Batista R. Ferulic acid and naturally occurring compounds bearing a feruloyl moiety: A review on their structures, occurrence, and potential health benefits. Compr Rev Food Sci F 2017; 16: 580-616.
[8]
Kumar N, Pruthi V. Potential applications of ferulic acid from natural sources. Biotechnol Rep 2014; 4: 86-93.
[9]
Middleton E, Kandaswami C, Theoharides TC. The effects of plants flavonoids on mammalian cells: Implication for inflammation, heart diseases and cancer. Pharmacol Rev 2000; 52: 673-839.
[10]
Angiolella L, Sacchetti G, Efferth T. Antimicrobial and antioxidant activities of natural compounds. Evid Based Complement Alternat Med 2018; 20181945179
[http://dx.doi.org/10.1155/2018/1945179]
[http://dx.doi.org/10.1155/2018/1945179]
[11]
Hollman PC, Katan MB. Bioavailability and health effects of dietery flavonols in man. Arch Toxicol Suppl 1998; 20: 237-48.
[12]
Srinivasan M, Sudheer AR, Menon VP. Ferulic acid: Therapeutic potential through its antioxidant property. J Clin Biochem Nutr 2007; 40(2): 92-100.
[13]
Kanaski J, Aksenova M, Stoyanova A, Butterfield DA. Ferulic acid antioxidants protection against hydroxyl and phenoxyl radicals oxidation in synaptosomal and neuronal cell culture system in vitro: Structure activity studies. J Nutr Biochem 2002; 13: 273-81.
[14]
Wright LE, Frye JB, Gorti B, Timmermann BN, Funk JL. Bioactivity of turmeric-derived curcuminoids and related metabolites in breast cancer. Curr Pharm Des 2013; 19(34): 6218-25.
[15]
Lampiasi N, Montana G. An in vitro inflammation model to study the Nrf2 and NF-κB crosstalk in presence of ferulic acid as modulator. Immunobiology 2018; 223(4-5): 349-55.
[17]
De Eds F, Booth AN, Jones FT. Methylation and dehydroxylation of phenolic compounds by rats and rabbits. J Biol Chem 1957; 225: 615-21.
[19]
Ou L, Kong LY, Zhang XM, Niwa M. Oxidation of ferulic acid by momordicacharantia peroxidase and related anti-inflammation activities changes. Biol Pharm Bull 2003; 26: 1511-6.
[20]
Tetuska T, Baier LD, Morrison AR. Antioxidants inhibit interleukin-1 induced cyclooxygenases and nitric oxides aynthase expression in rat mesangial cells. Evidence for post transcriptional regulation. J Biol Chem 1996; 271: 1168-9.
[21]
Hosoda A, Ozaki Y, Kashiwada A, Mutoh M, Wakabayashi K, Mizuno K, et al. Synthesis of ferulic acid derivatives and their suppressive effects on cyclooxygenase-2-promotor activity. Bioorg Med Chem 2002; 10: 1189-96.
[22]
Sakai S, Ochiai H, Nakajima K, Terasawa K. Inhibitory effects of ferulic acids on macrophage cell line, Raw 264.7. Cytokine 1997; 9: 242-8.
[23]
Argano M, Parola S, Tamagno E. Oxidative dereangement in rat synaptosomes induced by hyperglycemia: Restorative effects of dehydoepiandosterone treatment. Biochem Pharmacol 2000; 60: 389-95.
[24]
Villa-Caballero C, Nava-Ocampo AA, Frati-Munari AC, Poncemonter H. Oxidative stress, should it be measured in diabetic patient. Gac Med Max 2000; 136: 249-56.
[25]
Kalita H, Boruah DC, Deori M, Hazarika A, Sarma R, Kumari S, et al. Antidiabetic and antilipidemic effect of Musa balbisiana root extract: A potent agent for glucose homeostasis in streptozotocin-induced diabetic rat. Front Pharmacol 2016; 7: 102.
[26]
Balasubashini MS, Rukkumani R, Menon VP. Protective effects of ferulic acid on hyperlipidemic diabetic rats. Acta Diabetol 2003; 40: 118-22.
[27]
Nardini M, Ghiselli A. determination of free and bound phenolics acid in beer. Anal Nutr Clin Methods 2004; 84: 137-43.
[28]
Karamac M, Koleva L, Kancheva VD, Amarowicz R. The structure-antioxidant activity relationship of ferulates. Molecules 2017; 22(4): 527.
[29]
Dedoussis GVZ, Kaliora AC, Andrikopoulos NK. Effects of phenols on Natural Killer (NK) cell mediated death in the K562 human leukemic cell line. Cell Biol Int 2005; 29: 884-9.
[30]
Loo G. Redox-senstive mechanism of phytochemicals mediated inhibition of cancer cell proliferation. J Nutr Biochem 2003; 14: 64-73.
[31]
Asanoma M, Takahashi K, Miyabe M, Yoshimi N, Mori H, Kawazoe Y. Inhibitory effects of topical applicatons of polymerized ferulic acid, a synthetic lignin, on tumor promotion in mouse skin two stages of tumorogenesis. Carcinogenesis 1993; 12: 1321-5.
[32]
Lesca P. Protective effects of ellagic acid and other plants phenols on benzo[a] purene-induced neoplasia in mice. Carcinogenesis 1983; 4: 1651-3.
[33]
Stich HF, Ohshima H, Pignatelli B, Michelon J, Bartisch H. Inhibitory effects of betel nut extracts on endogenous nitrosation in humans. J Natl Cancer Inst 1983; 70: 1047-50.
[34]
Newmark H. Plant phenols as inhibitor of mutational and precarcinogenesis events. Can J Physiol Pharmacol 1987; 65: 461-6.
[35]
Kuenzing W, Chau J, Norkus E, Holowaschenko H, Newmark H, Mergens W, et al. Caffeic and ferulic acid as blockers of nitrosamine formation. Carcinogenesis 1984; 5: 309-13.
[36]
Black HS, De Grujil FR, Forbes PD, Claver JE, Anathaswamy HN, De Fabo EC, et al. Photocarcinogenesis: An overview J. Photochem Photobiol 1997; 40: 29-47.
[37]
Paiva LBD, Goldbeck R, Santos WDD, Squina FM. Ferulic acid and derivatives: Molecules with potential application in the pharmaceutical field. Braz J Pharm Sci 2013; 49(3): 395-411.
[38]
Butterfield D, Castergra A, Pocernich C, Drake J, Scapagini G, Calabrese V. Nutritional approaches to combat oxidative stress in Alzheimer diseases. J Nutr Biochem 2002; 13: 444.
[39]
Barone E, Calabrese V, Mancuso C. Ferulic acid and its therapeutic potential as a hormetin for age-related diseases. Biogerontology 2009; 10(2): 97-108.
[40]
Joshi G, Perlugi M, Sultana R, Agrippino R, Calabrese V, Butterfield DA. In vivo protection of synaptosomes by ferulic acid ethylester from oxidative stress mediated by 2,2-Azo bis (2-amido-propane) dihydrochloride (AAPH) or Fe2+/H2O2: Insight into mechanisms of neuroprotective and revelence to oxidative stress-related neurodegenerative disorders. Neurochem Int 2006; 48: 318-27.
[41]
Kim HS, Cho JY, Kim DH, et al. Inhibitory effects of long term administration of ferulic acid on microgilal activation induced by intercerebroventricular injection of beta-amyloid oeotide (1-42) in mice. Biol Pharm Bull 2004; 27: 120-1.
[42]
Kim EO, Min KJ, Kwon TK, Um BH, Moreau RA, Choi SW. Anti-inflammatory activity of hydroxycinnamic acid derivatives isolated from corn bran in lipopolysaccharide-stimulated Raw 264.7 macrophages. Food Chem Toxicol 2012; 50(5): 1309-16.
[43]
Sultana R, Ravagna A, Mohmmad‐Abdul H, Calabrese V, Butterfield DA. Ferulic acid ethyl ester protects neurons against amyloid β‐peptide (1-42)-induced oxidative stress and neurotoxicity: Relationship to antioxidant activity. J Neurochem 2005; 92(4): 749-58.
[44]
Scapagini G, Butterfield DA, Colomrita C, Sultana R, Pascale A, Calabrese V. Ethyl ferulate, a lipophilic polyphenol, induces HO-1 and protects rats neurons against oxidative stress. Antioxid Redox Signal 2004; 6(5): 811.
[45]
Maruyama H, Kawakami F, Lwin TT, Imai M, Shamsa F. Biochemical characterization of ferulic acid and caffeic acid which effectively inhibit melanin synthesis via different mechanisms in B16 melanoma cells. Chem Pharm Bull 2018; 41(5): 806-10.
[46]
Murray JC, Burch JA, Strelein RD, Iannacchione MA, Hall RP, Pinnel SR. A topical antioxidants solution containing vitamins Cand E stabilized by ferulic provides protection for human skin against damage caused by ultraviolet irridation. J Am Acad Dermatol 2008; 59: 418-25.
[48]
Yilidiz D, Ercal N, Armstrong DW. Nicotine enantiomers and oxidants stress. Toxic 1998; 130: 155-65.
[49]
Sudheer AR, Kalpana C, Srinivash M, Menon VP. Ferulic acid modulation aleters lipid proliferation and peroxidation status in circulation during nicotine- induced toxicity, A dose depended study. Toxicol Mech Methods 2005; 15: 375-81.
[50]
Ohsaki AY, Shisakawa H, Koseki T, Komai M. Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneousely hypertensive rats. J Agric Food Chem 2008; 56: 2825-30.
[51]
Wang B, Ouyang J, Liu Y, Yang L, Wei K, Yang L. Sodium ferulate inhibits atherosclerogenesis in hyperlipidemia rabbits. J Cardiovasc Pharmacol 2004; 43: 549-54.
[52]
Sharma A, Sharma P, Singh HT, Sharma AK. Phytochemical and
Pharmacological Properties of Flavonols. In: eLS. John Wiley &
Sons Ltd. 2018, Chichester. http://www.els.net
[http://dx.doi.org/10.1002/9780470015902.a0027666]
[http://dx.doi.org/10.1002/9780470015902.a0027666]
[53]
Kashyap D, Sharma A, Tuli HS, Sak K, Punia S, Mukherjee TK. Kaempferol-A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J Funct Foods 2017; 30: 203-19.
[54]
Kashyap D, Kumar G, Sharma A, Sak K, Tuli HS, Mukherjee TK. Mechanistic insight into carnosol-mediated pharmacological effects: Recent trends and advancements. Life Sci 2017; 169: 27-36.
[55]
Kashyap D, Sharma A, Sak K, Tuli HS, Buttar HS, Bishayee A. Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy. Life Sci 2018; 194: 75-87.
[56]
Kashyap D, Sharma A, Tuli HS, Sak K, Mukherjee T, Bishayee A. Molecular targets of celastrol in cancer: Recent trends and advancements. Crit Rev Oncol Hematol 2018; 128: 70-81.
[57]
Kashyap D, Sharma A, Tuli HS, Sak K, Garg VK, Buttar HS, et al. Apigenin: A natural bioactive flavone-type molecule with promising therapeutic function. J Funct Foods 2018; 48: 457-71.
[58]
Sharma A, Tuli HS. Natural moieties as promising anti-cancer drugs. J Biol Chem Sci 2017; 4(1): 301-3.
[59]
Yadav P, Jaswal V, Sharma A, Kashyap D, Tuli HS, Garg VK, et al. Celastrol as a pentacyclic triterpenoid with chemopreventive properties. Pharm Pat Anal 2018; 7(4): 155-67.
[http://dx.doi.org/10.4155/ppa-2017-0035]
[http://dx.doi.org/10.4155/ppa-2017-0035]
[60]
Kashyap D, Sharma A, Tuli HS, Punia S, Sharma AK. Ursolic acid and oleanolic acid: Pentacyclic terpenoids with promising anti-inflammatory activities. Recent Pat Inflamm Allergy Drug Discov 2016; 10(1): 21-33.
[61]
Sharma A, Kashyap D, Sak K, Tuli HS, Sharma AK. Therapeutic charm of quercetin and its derivatives: A review of research and patents. Pharm Pat Anal 2018; 7(1): 15-32.
[http://dx.doi.org/10.4155/ppa-2017-0030]
[http://dx.doi.org/10.4155/ppa-2017-0030]
[62]
Chakrawarti L, Agrawal R, Dang S, Gupta S, Gabrani R. Therapeutic effects of EGCG: A patent review. Expert Opin Ther Pat 2016; 26(8): 907-16.
[http://dx.doi.org/10.1080/13543776.2016.1203419]
[http://dx.doi.org/10.1080/13543776.2016.1203419]
[63]
Di Martino RM, Luppi B, Bisi A, et al. Recent progress on curcumin-based therapeutics: A patent review (2012-2016). Part I: Curcumin. Expert Opin Ther Pat 2017; 27(5): 579-90.
[http://dx.doi.org/10.1080/13543776.2017.1276566]
[http://dx.doi.org/10.1080/13543776.2017.1276566]
[64]
Hussain H, Green IR. A patent review of the therapeutic potential of isoflavones (2012-2016). Expert Opin Ther Pat 2017; 27(10): 1135-46.
[65]
Pan Z, Simonnet JT, Murtaugh A, Spomer JI. Cosmetic compositions
containing at least one flavonoid, ferulic acid and vitamin
c or resveratrol. EP2906037 (2018).
[66]
Beilfuss W, Weber K, Oltmanns P, et al. Composition comprising ferulic acid
ethyl ester and aryl alkanol. US9907737 (2018).
[67]
Arancibia JSA, Diez AEA, Rios HG, Pina RN. Dietary
supplement based on ethyl ferulate. US9943496 (2018).
[68]
Zhou R, Yu X. Methods of making vanillin via the microbial
fermentation of ferulic acid from eugenol using a plant dehydrogenase.
US9932610 (2018).
[69]
Junrong D, Chong C, Hongjing Z, Junrong D, Chong C, Hongjing Z. A kind of purposes of ferulic acid derivative as nerve
protection medicine. CN104958287 (2019).
[70]
Hong W, Huan Y, Minhua Z, Kun F. Preparation method of
simultaneously embedding nanofibers fish oil and ferulic acid film
and applications. CN106149195 (2018).
[71]
Jian M, Cuicui L, Xiangyong M, Jingyu X, Shuangping L. A
rich source of ferulic acid functional wine and production method.
CN104762220 (2018).
[72]
Guizhen G, Jian C, Sun JJ, Yuyao YL. A kind of ferulic acid
derivative, preparation and its application. CN105693689 (2016).
[73]
Jianbin L, Chen L, Hui N, Yong Y, Peihua L, Yu C. One
kind of ferulic acid / chitosan contained vitamin preparation B1 and
vitamin B6 microcapsules and applications. CN105661549 (2018).
[74]
Jian M, Cuicui L, Shuangping L, Zhilei Z, Jingyu X. Speciesrich
ferulic acid functional vinegar and its production method.
CN104911113 (2018).
[75]
Kamishi H, Kamishi H, Seto K, et al. Hiyoshi, Shun, H., Oobuchi,
O. Reduced production method of cinnamic acid analogues containing
fractions. JP6333509 (2018).
[76]
Rongbiao P, Xixin H, Xiaohong Y, et al. Caffeic acid and
ferulic acid homodimer, their preparation and pharmaceutical
compositions thereof. CN104557588 (2016).
[78]
Ling L, Zhaohui J, Shunan Z, et al. Species Strain ferulic acid production engineering,
construction method and biological conversion process.
CN104928224 (2018).
[79]
Hamanaka R, Hamanaka S, Kawazu S, Shoko K, Shoichi S. A method of manufacturing ferulic acid. JP6343967 (2018).
[80]
Zhaojian G, Dongxing W, Jinhui H, et al. One kind of feruloyl esterase producing
Bacillus licheniformis and its application. CN104894017
(2018).
[81]
Jian M, Cuicui L, Shuangping L, Zhongwei J, Xiangyong M. Yield feruloyl esterase strain cladosporioides and brewing vinegar
application. CN105238703 (2018).
[82]
Jian K, Zhenshang X. Lactobacillus producing a macrophage
starch feruloyl esterase and its application. CN105154371 (2018).
[83]
Zhaojian G, Enzhen L, Zehong C, Huigang S, Dawei X, Xianyao Y. Bacillus licheniformis flask liquid fermentation process
for the preparation of heat-feruloyl esterase. CN104845951
(2018).
[86]
Kawahira S, Kawagami S, Kotaya K, et al. Stabilization method of
stilbenes contained in the plant extract or a solution thereof, and, a
plant extract or a solution thereof containing stilbenes. JP6343126
(2018).
[87]
Pan Z, Guo M, Simonnet JT. Methods and compositions for
providing broad spectrum photo protection using antioxidants.
US10137072 (2018).
[88]
Maeda Y, Maeda Y, Hua T, et al. The method for producing a
physiologically active substance from rice bran. JP6335026 (2018).
[89]
Fukuda N, Michihata N, Michita M, et al. Myoglobin-containing food freshness deterioration prevention material
and use thereof. JP6420830 (2018).
[90]
Tono Y, Tono Y. Guaiacol-containing composition having a
microorganism and microbial growth promoting activity were selected
guaiacol recognizability to index. JP6347563 (2018).
[91]
Ii JA, Dinardo LJC. Botanical antioxidant compositions and
methods of preparation and use thereof. CA2842946 (2018).
[92]
Natale AS, Adriano F, Roberto SGC, Marcolongo F. Compositions for treating Helicobacter pylori infection.
EP2575809 (2018).
[93]
Manku M, Climax J, Coughlan D. Pharmaceutical compositions
comprising DGLA and/or 15-HETrE and methods of use thereof.
US9855236 (2018).
[94]
Brian D, Lynn GOB, Lynn MR, Anne MR, Anne KS, Sharon K. Filament and a manufacturing method thereof including
microorganisms. JP6431080 (2018).
[95]
Zhipei S, Wenmin L. Lin Tao, Y., Qinge, M., Changzhong, M.,
Wanli, P., Tao, L., Limin, G. Cyclic amine of 4-alkoxy-3-methoxycinnamic acid ester compounds, preparation method and use thereo.
CN105622488 (2018).
[96]
Ip Full Asset Ltd. Composition for hair strengthening and their
application for strengthening of hair. DE202016008643 (2018).
[97]
Ip Full Asset Ltd. Hair restorative composition and a kit for
strengthening of hair. DE202017004939 (2018).
[98]
Giuliani G, Benedusi A, Marzani B, Baroni S, Pini E, Gandolfi R. Compounds with a combined antioxidant activity against
free radicals together with an anti-inflammatory action, and pharmaceutical
and cosmetic compositions containing them for the
treatment of skin and hair. EP3116849 (2018).
[100]
Lockridge J, Orr CL, Prater DL, Zaeska V. Compositions,
methods and products oxidative hair dye. ES2655048 (2018).
[101]
Zhipei S, Wenmin L. Lin Tao, Y., Qinge, M., Changzhong, M.,
Wanli, P., Tao, L., Limin, G. Species-alkoxy-3-amine 4-methoxyphenyl
cinnamic acid amide compounds, preparation and use
thereof. CN105732479 (2018).
[102]
Zhiqin Z, Zhang YJ, Xi H, Zhang W. Samples having a total
antioxidant online rapid detection method. CN105241965 (2018).
[103]
Zhipei S, Wenmin L. Lin Tao, Y., Qinge, M., Changzhong, M.,
Wanli, P., Tao, L., Limin, G. 4- yl carbamate 3-methoxy cinnamic
acid aminoalkyl cyclic amide compound, preparation and use
thereof. CN105837497 (2018).
[104]
Zhipei S, Wenmin L. Lin Tao, Y., Qinge, M., Changzhong, M.,
Wanli, P., Tao, L., Limin, G. 4- Amine species alkoxy-3-methoxy
cinnamate compounds, preparation and use thereof . CN105732405
(2018).
[107]
Kuwashi M, Tanba FR, Hua T, et al. Species 4- yl carbamate 3-methoxy cinnamic acid amides
and aminoalkyl preparation and use. CN105646289 (2018).
[108]
Hart AD, Kramer G, Bacchus M. The use of flavor compounds
for metal ions stable. CN103371216 (2018).
[109]
Hiroshi K, Vincent NG. Lycopene-containing water-oil emulsion
composition and manufacturing method. CN104661739 (2018).
[110]
Mingming Z, Fenghong H, Chunfang X, Xia X, Ganchun D. Efficient methods of preparing acid glycerides. CN106086096
(2018).
[112]
Lieb B, Schmitt P. Photoprotektives oleoresin emulgate for oral
administration as a medical device. DE202017006637 (2018).
[113]
Shiraishi N, Shiraishi N, Adachi M, Adachi M. Rice bran film
and manufacturing method thereof. JP6317903 (2018).
[114]
Hirotsugu Mitsubishi Chemical Corporation Kido. Deterioration
preventing agent. EP1867699 (2018).
[115]
Sorensen JF, Mikkelson R, Polson CH, Crow KM. Oligosaccharides
produced by the enzymatic sidestream cereals or cereal.
CN102316751 (2018).
[116]
Almirante N, Almirante N, Stroni L, et al. Quinone-based nitric oxidedonating
compounds for eye drops. JP6306148 (2018).
Related Journals
Current Medicinal Chemistry
Current Pharmaceutical Design
Current Topics in Medicinal Chemistry
Current Respiratory Medicine Reviews
Infectious Disorders - Drug Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets
Anti-Infective Agents
Coronaviruses
Recent Advances in Inflammation & Allergy Drug Discovery
Current Probiotics
Article Metrics
56
12